Earnings call transcripts

Earnings call transcripts with speakers and Q&A, usually within hours. Each one comes with a summary, the guidance management gave, and what analysts pressed on, free to read.

3,605 transcripts · 1,695 companiesHow to read a callBy API: the earnings call transcripts API.

Older calls

Page 101 of 301 · 3,605 calls

  • Azenta (AZTA) Q3 2026 earnings call

    Management framed the quarter as improved execution, not proof of recovery, emphasizing recurring-revenue strength and continued turnaround work amid uneven demand.

    Aug 05, 2026Mildly positive0.25
  • Cencora (COR) Q3 2026 earnings call

    Management framed the quarter as a planned second-half acceleration, with specialty utilization and MSO execution offsetting pricing and customer pressures.

    Aug 05, 2026Confident0.82
  • Walt Disney Company (The) (DIS) Q3 2026 earnings call

    Management emphasized diversified growth, disciplined investment and integrated fan relationships, while downplaying promotions and uneven theatrical results as strategic concerns.

    Aug 05, 2026Confident0.82
  • Amprius Technologies (AMPX) Q2 2026 earnings call

    Management framed accelerating drone demand and new customer wins as drivers of a second revenue-forecast increase, while emphasizing manufacturing execution and mix-dependent margins.

    Aug 05, 2026Confident0.82
  • Angi (ANGI) Q2 2026 earnings call

    Management framed Q2 as a macro- and mix-disrupted reset, emphasizing pro-capacity recovery, large-pro penetration, and AI execution as 2027 growth levers.

    Aug 05, 2026Mildly positive0.25
  • Archrock (AROC) Q2 2026 earnings call

    The call reinforced confidence in a multiyear compression upcycle while acknowledging near-term cost, maintenance-timing and equipment-availability constraints.

    Aug 05, 2026Confident0.78
  • Astec Industries (ASTE) Q2 2026 earnings call

    Management portrayed broad demand strength despite asphalt delivery deferrals, lowering EBITDA guidance primarily for timing rather than weaker bookings.

    Aug 05, 2026Positive0.55
  • Biocryst Pharmaceuticals (BCRX) Q2 2026 earnings call

    The call added confidence in Orladeyo’s durable demand while framing external innovation and cost discipline as the next growth engine.

    Aug 05, 2026Confident0.82
  • Bioventus (BVS) Q2 2026 earnings call

    Management framed the quarter as disciplined investment behind durable HA growth, with strategic alternatives adding a new shareholder-value catalyst.

    Aug 05, 2026Confident0.72
  • CDW (CDW) Q2 2026 earnings call

    Management framed AI as a broad, multi-year, full-stack opportunity while emphasizing normalized supply, stronger leverage, and disciplined prudence in the outlook.

    Aug 05, 2026Confident0.82
  • Eos Energy Enterprises (EOSE) Q2 2026 earnings call

    Management framed the quarter around deliberate factory consolidation, accelerating Frontier Power conversion, and improving fleet evidence despite near-term revenue tradeoffs.

    Aug 05, 2026Confident0.72
  • Flutter Entertainment (FLUT) Q2 2026 earnings call

    Management framed the quarter as operationally encouraging but deliberately sacrificing near-term U.S. profitability to rebuild customer momentum for 2027.

    Aug 05, 2026Cautious-0.10

Companies covered

1,695 companies

160 more under A